Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 618

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 618
---
 indicated (in thousands):

| ​                                                   
 ​                                                   | ​ 
 ​ | ​ 
 ​ | Nine Months EndedSeptember 30, 
 2024                           |   |         |   | ​ | ​ | 2023 |   |         |   | ​ 
 ​ | ​ 
 ​ | Year Ended December 31, 
 2023                    |   |         |   | ​ | ​ | 2022 |   |         |   | ​ 
 ​ |
|:----------------------------------------------------|:--|:--|:-------------------------------|:--|--------:|:--|:--|:--|:-----|:--|--------:|:--|:--|:--|:------------------------|:--|--------:|:--|:--|:--|:-----|:--|--------:|:--|:--|
| Net cash used in operating activities               | ​ | ​ | ​                              | $ | -13,472 | ​ | ​ | ​ | ​    | $ | -15,291 | ​ | ​ | ​ | ​                       | $ | -21,040 | ​ | ​ | ​ | ​    | $ | -17,866 | ​ | ​ |
| Net cash provided by (used in) investing activities | ​ | ​ | ​                              | ​ |       — | ​ | ​ | ​ | ​    | ​ |  22,468 | ​ | ​ | ​ | ​                       | ​ |  22,468 | ​ | ​ | ​ | ​    | ​ | -22,000 | ​ | ​ |
| Net cash (used in) provided by financing activities | ​ | ​ | ​                              | ​ |      -9 | ​ | ​ | ​ | ​    | ​ |       2 | ​ | ​ | ​ | ​                       | ​ |       2 | ​ | ​ | ​ | ​    | ​ |       4 | ​ | ​ |
| Net (decrease) increase in cash                     | ​ | ​ | ​                              | $ | -13,481 | ​ | ​ | ​ | ​    | $ |   7,179 | ​ | ​ | ​ | ​                       | $ |   1,430 | ​ | ​ | ​ | ​    | $ | -39,862 | ​ | ​ |

353

TABLE OF CONTENTS

Operating Activities

Net cash used in operating activities was $13.5 million for the nine months ended